Experiencia de un hospital universitario en el manejo de púrpura trombótico trombocitopénico-microangiopatía trombótica no inmune refractaria o en recaída tratado con rituximab: Report of eight cases / Treatment of thrombotic thrombocytopenic purpura with rituximab
Rev. méd. Chile
; 143(6): 809-811, jun. 2015. tab
Article
en Es
| LILACS
| ID: lil-753523
Biblioteca responsable:
CL1.1
ABSTRACT
Thrombotic thrombocytopenic purpura, an immune/non-immune thrombotic microangiopathy (TTP/TMA) is associated with high morbidity and mortality, even with appropriate treatment. In patients refractory to standard treatment with plasmapheresis there is no certainty about the best therapeutic strategy. This report shows our experience in eight refractory patients who survived after treatment with rituximab.
Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Púrpura Trombocitopénica Trombótica
/
Rituximab
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
Es
Revista:
Rev. méd. Chile
Asunto de la revista:
MEDICINA
Año:
2015
Tipo del documento:
Article